S. Korea's biopharmaceutical company said that its sales amounted to $840 million in the second quarter of this year, up 35.2% from a year earlier. Celltrion’s Q2 profit jumps 77% year-on-year
S. Korea's biopharmaceutical company said that its sales amounted to $840 million in the second quarter of this year, up 35.2% from a year earlier. 
3 months ago
42
English (US) ·